Researchers discover a pathway in that mouse brain that regulates fear memory and behavior
Cold Spring Harbor, NY — Some people have no fear, like that 17-year-old kid who drives like a maniac. But for the nearly 40 million adults who suffer from anxiety disorders, an overabundance of fear rules their lives. Debilitating anxiety prevents them from participating in life’s most mundane moments, from driving a car to riding in an elevator. Today, a team of researchers at Cold Spring Harbor Laboratory (CSHL) describes a new pathway that controls fear memories and behavior in the mouse brain, offering mechanistic insight into how anxiety disorders may arise.
It is hard to imagine that an intangible emotion like fear is encoded within neuronal circuits, but researchers have found that fear is stored within a distinct region of the brain. “In our previous work, we discovered that fear learning and memory are orchestrated by neurons in the central amygdala,” explains CSHL Associate Professor Bo Li, who led the team of researchers. But what controls the central amygdala?
One possible candidate was a cluster of neurons that form the PVT, or paraventricular nucleus of the thalamus. This region of the brain is extremely sensitive to stress, acting as a sensor for both physical and psychological tension.
As described in work published today in Nature, the researchers looked to see if the PVT plays a role in fear learning and memory in mice. “We found that the PVT is specifically activated as animals learn to fear or as they recall fear memories,” says Li. The team was able to see that neurons from the PVT extend deep into the central amygdala. Disrupting the connection significantly impaired fear learning.
Because the link between the PVT and the central amygdala is a critical component of fear learning, it represents an ideal target for potential drugs to treat anxiety disorders. But how is this link established? The researchers looked to data from people with post-traumatic stress disorder (PTSD) to identify chemical messengers that might connect the two structures. They focused on a molecule called BDNF that has been implicated in anxiety disorders. BDNF is a well-known neural growth factor that plays an important role in stimulating the birth of new neurons as well as new connections between neurons. Patients with anxiety disorders frequently have mutations in BDNF, suggesting that it might have a role in fear learning and memory.
The researchers worked to determine if BDNF plays a role in fear, and specifically if it affects the connection between the PVT and central amygdala in mice. They found that the addition of BDNF in the central amygdala acutely activates its neurons, triggering a fear response in animals that have not previously been exposed to a fearful stimulus, and promoting the formation of long-term fear memories. “We established that this is a regulatory circuit that controls fear in mice: BDNF is the chemical messenger that allows the PVT to exert control over the central amygdala,” Li explains.
The results, he says, are consistent with what clinicians have seen and may help to explain some of the underlying pathology in patients. “Our work provides mechanistic insight into a novel circuit that controls fear in the brain, and provides a target for the future treatment of anxiety disorders,” says Li.
Written By: Jaclyn Jansen, Science Writer | firstname.lastname@example.org | 516-367-8455
This work was supported by the US National Institutes of Health, the Dana Foundation, NARSAD, Louis Feil Trust, the Stanley Foundation, and a Harvey L. Karp Discovery Award.
“The paraventricular thalamus controls a central amygdala fear circuit” appears online in Nature on January 19, 2015. The authors are: Mario Penzo, Vincent Robert, Jason Tucciarone, Dimitri De Bundel, Minghui Wang, Linda Van Aelst, Martin Darvas, Luis Parada, Richard Palmiter, Miao He, Z. Josh Huang, and Bo Li. The paper can be obtained online at: http://dx.doi.org/10.1038/nature13978
About Cold Spring Harbor Laboratory
Founded in 1890, Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. Home to eight Nobel Prize winners, the private, not-for-profit Laboratory employs 1,100 people including 600 scientists, students and technicians. The Meetings & Courses Program annually hosts more than 12,000 scientists. The Laboratory’s education arm also includes an academic publishing house, a graduate school and the DNA Learning Center with programs for middle and high school students and teachers. For more information, visit www.cshl.edu
Ph.D., The University of British Columbia, 2003